Vitamin B12 (Cobalamin, Cyanocobalamin) Market

Key data points: Market size in 2027 = $867 million and 2035 = $1470 million, growth forecast = 2.9% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in vitamin B12 (cobalamin, cyanocobalamin) market to 2035 by type (cyanocobalamin injection, cyanocobalamin oral, and cyanocobalamin spray), application (hospitals, clinics, drugstore, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World) Vitamin B12 (Cobalamin, Cyanocobalamin) Market The future of the global vitamin b12 (cobalamin, cyanocobalamin) market looks promising with opportunities in the hospital, clinic, and drugstore markets. The global vitamin b12 (cobalamin, cyanocobalamin) market is expected to reach an estimated $1470 million by 2035 from $867 million in 2027 with a CAGR of 2.9% from 2027 to 2035. The major drivers for this market are the increasing awareness of vitamin deficiencies, the rising demand for energy-boosting supplements, and the growing popularity of plant-based diets. • Lucintel forecasts that, within the type category, cyanocobalamin injection is expected to witness the highest growth over the forecast period due to more rapid absorption and efficacy of cyanocobalamin injections. • Within the application category, clinics is expected to witness the highest growth over the forecast period due to rising cases of vitamin B12 deficiency diagnosed in clinics. • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to growing awareness of deficiencies and access to healthcare in the APAC region. Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below. Emerging Trends in Vitamin B12 (Cobalamin, Cyanocobalamin) Market The market for vitamin B12 is predicted to transform and focus on preventative health and wellness. According to Lucintel, the greatest growth opportunity for the market will be created by the increase in vegan/plant based diets by 2027, especially with the rising population, improving quality of logistics and e-commerce. Lucintel also noted that in order to successfully compete in the market, companies would have to focus on innovation of product offerings and expand their regional manufacturing capacities. • Preventive Health: The adult reference value for vitamin B12 is 2.4 mcg. In 2025, numerous brands launched vitamin B12 supplements in sprays and gummies. In 2025 and beyond, it is expected that the purchase of vitamin B12 supplements would be driven by consumer interest in general health and wellness. • Fortification of Plant Based Products: In 2025-2027, with the increasing trend of flexitarian diets, the supplementation of plant based products (i.e. dairy alternatives, meat alternatives, cereals and other food products) with vitamin B12 would become common. • Premium Supplements: In 2025, product innovations in the vitamin B12 supplements market included the use of methylcobalamin and other atypical delivery formats (i.e. liquids, sublingual tablets and patches). In order to charge a premium, supplement manufacturers would have to focus on product differentiation with claims around improved bioavailability and/or form over traditional tablets. • Digital Selling and Personalization: Education on symptom recognition will increase and be combined with other digital offerings, such as subscription replenishment and at-home nutrient testing. Direct-to-consumer pharmacies will use the internet to expand their customer base and offer customized dosages and repeat-purchase programs. • Diversification of Supply Chains: In 2025-2027, greater emphasis will be placed on the resiliency of the supply chain, specifically on the raw material fermentation and the sourcing of pharmaceutical ingredients, as well as the location of the packaging. This will alter how raw material and pharmaceutical supply chains are managed. Demand for pharmaceutical grade vitamin B12 will continue due to the at risk population including the elderly, patients with malabsorption, and people following restrictive diets. The relaxation of some regulations will allow suppliers more latitude in claiming and promoting their products. Fortified foods and the internet will allow more vendors to sell vitamins and other pharmaceuticals. The main competition will be for the best and most reliable source of vitamins. Recent Developments in the Vitamin B12 (Cobalamin, Cyanocobalamin) Market Between now and 2027, the market for Vitamin B12 will experience rising levels of activity due to heightened demand for dietary supplements and fortified products as well as medical nutrition. The firm expects continuing market expansion during this period. However, industry concentration, pricing, regulatory environment and raw material sourcing will impact market performance. • Fermentation: Several producers have invested in large-scale fermentation plants to enhance batch consistency and reduce supply concentration. In March 2025, one of the largest producers in Asia announced plans to build a plant to produce 2,000 metric tons of vitamins per year. During the next three to five years, large-scale contracts and plant fermentation will reduce supply risks. • Raw Materials: Methylcobalamin is substituting cyanocobalamin in dietary supplements and other higher end products. In February 2025, a dietary supplement contained 1,000 micrograms of Methylcobalamin. Increased usage of methylcobalamin will increase raw material demand and Justify higher prices. • Food and Beverage Industry Partnerships: The formation of alliances between food and beverage producers to create fortified cereal and other functional drinks will increase the channels of distribution of Vitamin B12 and promote market expansion. In May 2025, a food and beverage company alliances with a nutrition company to launch a fortified product that contained 2.5 micrograms of Vitamin B12. • Closer Scrutiny of Supplements: Authorities are requiring stricter standards for supplement claims, dosage forms, and composites. Starting in January 2026, a major regulated marketplace rolled out a compliance program for more than 20 vitamin categories. Continued, deviation-intolerant focus on product quality and processes will grant a competitive edge to select suppliers. • Growing Contracts for Clinical Nutrition: Products by hospitals and contract manufacturers is fueled by the increasing demand for injectable and oral B12 for management of vitamin B12 deficiency. One agreement, in August 2025, was awarded to a supplier for the provision of 500,000 doses for public sector B12 deficiency treatment. Further awards are expected for suppliers capable of providing B12 and other vitamins in pharmaceutical forms. There will be a shift in preference from conventional isolated supplements. Long-term opportunities will be in fortifying food and other forms of supplementation. Quality of raw materials will be critical. Companies with strong regulatory and fermentation capacities will be beneficiaries. Strategic Growth Opportunities in the Vitamin B12 (Cobalamin, Cyanocobalamin) Market VITAMIN B12 (COBALAMIN AND CYANOCOBALAMIN) MARKET is expected to show growth in the forthcoming years due to numerous reasons such as increase in elderly population and the preference for vegan diet. Also, recent trends in food fortification and other precautionary and health promoting diet have created a great business potential for this market. As mentioned by Lucintel, possibilities are available to explore beyond conventional tablets. Depending on the climate and formulation constraints, vitamin b12 can be formulated in such a way that it increases repetitive purchase. • Various Delivery Systems: The use of different delivery systems to create tablets or other forms of vitamin b12 can help serve the customers who do not prefer injections or tablets. Also, the U.S. NIH released a document in January 2025 stating that 2.4 micrograms of vitamin b12 meets the daily requirement for an adult. Other delivery systems can be developed to ensure the dosage is met for a longer period of time. • Foods and Beverages: The fortification of bakery products, beverages, cereals, and sports nutrition can lead to regular consumption of vitamin b12. • Medical Nutrition: B12 can be formulated for health care personnel serving senior citizens to provide regular care and nutrition. • Plant-based and Precision Nutrition: Plant-based consumers, or in this case vegan consumers, rely on supplementation for vitamin B12. On April 2025, The Vegetarian Society revealed that B12 was one of the main nutrients that is at risk for vegans, and recommended fortifying it in foods or taking supplements. Individualized or personalized dosing and/or fortification can be an effective strategy in customer retention. • Emerging-market Manufacturing: The risk of importing raw materials and finished products can be off-set by producing in or nearer to areas with greater demand, such as South America, Africa, and parts of Asia. As of May 2025, it was estimated that the population of India was over 1.4 billion. Meeting the pharmacopeial standards would allow companies to produce and distribute medicines in India. Long-term, such companies would be able to develop and maintain a strong and stable clientele, and consumer, base. Affordability and reliability will help companies win over clients and longer-term contracts. Products that incorporate active pharmaceutical ingredients (APIs) or nutrients into common foods will gain popularity. Variations in active ingredient concentrations will require more stringent quality assurance, especially if trust and confidence has to be gained or rebuilt. Wryptical Vitamin B12 (Cobalamin, Cyanocobalamin) Market Drivers and Challenges Awareness of vitamin B12 deficiency and the adoption of dietary supplementation have positively influenced the vitamin B12 market. Regulations and policies on food fortification impact market expansion. Variations in regulations can impact market growth. Lucintel reports that advancements in food and supplement technologies help foster vitamin B12 market growth, and consumer and clinical trends will continue to focus on the reliable and safe supply of vitamins. The factors responsible for driving this market include: • Greater Awareness of Deficiency: Greater recognition of vitamin B12 deficiency amongst the aforementioned populations has resulted in an increase in tests and supplements. As of January 2025, the U.S. NIH was finalizing its recommendation for vitamin B12 at 2.4 mcg per day for adults. Thereby, increasing the demand for supplements and fortified foods. Additionally, with the advent of telehealth, as well as other preventative care and wellness programs, it is anticipated that dietary deficiency screening and other tests will increase, thereby, further growing the market for vitamin B12. • Plant-Based Food Fortification: Producers are ramping up supply to meet surging market demand for plant-based foods. Cobalamin deficiency remains of significant public health concern. In the interest of public health, manufacturers enhance plant-based foods, such as milk, cereals and meat alternatives, with cobalamin (2025). With the latest Dietary Guidelines for Americans (2025-2030), the U.S. Department of Health and Human Services advises all Americans to follow a healthy-eating pattern, which substantially promotes the consumption of fortified foods. Compared to the previous set of dietary guidelines, the new set places greater emphasis on fortified and/or functional foods. The new dietary guidelines provide an opportunity for fortified food manufacturers to introduce a greater variety of fortified foods to the U.S. market. • Product Reformulation: Functional folate and iron supplements are available in several forms, including sublingual tablets, oral sprays, and gummies. EFSA sets the referential daily intake for folate at 4 μg for the general population (18 years and older). Manufacturers may formulate their products based on the referential daily intake. Different delivery systems for folate and/or iron supplements improve convenience and provide greater choice for consumers with swallowing and/or absorption issues. In the next 5 years, premium, differentiated products are expected to abound. • Manufacturing and Cost Efficiency: Progress in automation of processing and packaging coupled with advances in purification and formulation result in greater consistency and reduced waste and costs in manufacture of various products. Vitamin B12 is produced by microbial fermentation and is available for use in pharmaceuticals, food and feed supplements. The World Health Organization (WHO) continues to recommend micronutrient interventions and support implementation by member countries up to 2025. This provides a timebound framework for production of micronutrients including B12. Improvement in technology and production in B12 producing countries should result in increased supply, reduced costs and greater accessibility in the developing countries in the coming years. • Regulatory and Public Health Support: Establishment of policies by National Governments for improvement of nutrition of the population sets minimum standards for food fortification and supplementation. In 2025, the WHO/Food and Agriculture Organization of the United Nations (FAO) Expert Committee on Vitamin and Mineral Nutrition continued to set standards for labeling and quality of vitamin and mineral food supplements. Manufacturing and distributing food supplements in accordance with established standards is expected to encourage producers to enter new and underdeveloped markets. Improved labeling and quality standards should facilitate the entry of new manufacturers. In the short to medium term, fortification of food and market interventions should increase the demand for food supplements and favor large and established manufacturers. The challenges facing this market include: • Dependence on Third-party Suppliers for Raw Materials: Production of Vitamin B12 is derived from microbial fermentation and may be susceptible to variations in the cost and availability of energy and other inputs, as well as disruptions in the supply chain. The World Bank projected elevated risks and uncertainties in the supply of raw materials and components in 2025. Like other suppliers, vitamin producers may experience raw material supply challenges that result in price increases and/or supply disruptions. • International Regulatory Variations: There are variances in requirements for permissible levels of vitamins in food, claims, labeling, and packaging, as well as differences in the procedures for gaining marketing authorization. Further, the framework for nutritional labeling may vary. In 2025, the EU maintained its prior requirements for the presentation and dossiers substantiating the safety of food supplements, and other Authorities continued to align their food supplement frameworks with the EU. For the next three to five years, additional requirements for evidence and justification for claims may be instituted. Significant variations may persist for raw material and packaging. • Consumer Misinformation: A distinction between cyanocobalamin and methylcobalamin may elude the average consumer. Misleading advertising may reinforce erroneous notions about supplements and their effects on energy, immunity, and weight. The FDA issued a statement in 2025 reminding the public that all supplements are devoid of efficacy and safety assessments (January 2025). In the short to medium term, the industry will need to strategically adjust to shifting market demands and oversight. Prioritizing good business practices, legitimate practitioner supervision, and substantiating claims will help bolster the industry and reassure the public. The trend toward awareness of vitamin B12 deficiency and greater consumption, as a result of changing dietary patterns and the growing prevalence of plant-based and fortified foods, creates a favorable business environment for many years to come. However, the industry may face similar limitations as other markets, including supply and demand imbalances due to inconsistent regulations and standards. The industry will generally rise and fall with the public's faith in an effective and reliable regulatory framework. The future of the industry will be determined by the industry's ability to incorporate innovation and best business practices to provide fully aligned and balanced nutrition to the public. List of Vitamin B12 (Cobalamin, Cyanocobalamin) Market Companies Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies vitamin b12 (cobalamin, cyanocobalamin) market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the vitamin b12 (cobalamin, cyanocobalamin) market companies profiled in this report include- • Luitpold Pharmaceuticals • Endo International • Sanofi-Aventis • Jamieson • Novartis Vitamin B12 (Cobalamin, Cyanocobalamin) Market by Segment The study includes a forecast for the global vitamin b12 (cobalamin, cyanocobalamin) market by type, application, and region. Vitamin B12 (Cobalamin, Cyanocobalamin) Market by Type [Value ($M) from 2019 to 2035]: • Cyanocobalamin Injection • Cyanocobalamin Oral • Cyanocobalamin Spray Vitamin B12 (Cobalamin, Cyanocobalamin) Market by Application [Value ($M) from 2019 to 2035]: • Hospitals • Clinics • Drugstore • Others Vitamin B12 (Cobalamin, Cyanocobalamin) Market by Region [Value ($M) from 2019 to 2035]: • North America • Europe • Asia Pacific • The Rest of the World Country Wise Outlook for the Vitamin B12 (Cobalamin, Cyanocobalamin) Market Fermentation based production of vitamin B12 is gaining traction and along with improvements in the quality of B12 production and the localization of pharmaceutical production is expected to positively impact the B12 market. From 2025 to 2027, market players are expected to focus on investment to enhance their production capacity of B12. These would be done in the form of new partnerships across the pharmaceutical, dietary supplements and food sectors. • United States: Continuing enforcement of rules by the FDA for the manufacture and distribution of dietary supplements will require supplement producers to demonstrate the identity, potency and stability of finished products. Producers able to demonstrate this are expected to gain market share. • China: The Chinese Food and Drug Administration (CFDA) has been continually enhancing the framework for registration of medical devices and active pharmaceutical ingredients. Chinese producers of vitamins are expected to enhance their documentation practices to meet requirements of the framework in order to gain market share in China and other regulated markets. • Germany: Investments by BASF for the next few years are likely to support their German operations. In February 2025, they announced planned capital investments of approximately 2.1 billion euros for the period ending 2024. While it is likely BASF is considering various reasons for these investments, these funds could support the specialty chemical platform and biotechnology capabilities, including specialty vitamins. • India: The Indian government’s ongoing efforts to promote the pharmaceutical sector gained further traction in 2025. The Production Linked Incentive Scheme and updated regulations for nutraceuticals strengthened the policy framework, and the Department of Pharmaceuticals approved over 15,000 crore rupees of investments under the Pharmaceuticals PLI Scheme. These policies should facilitate the establishment of integrated manufacturing facilities for vitamin B12, reducing the country’s reliance on imports. • Japan: The Ministry of Health, Labor and Welfare of Japan renewed the pharmaceutical policy and quality assurance for 2025. Combined with the country’s overall commitment to the health sector, these policies are expected to boost the demand for cyanocobalamin and other pharmaceutical products. Therefore, suppliers of these products can also expect similar policies and increased demand. Features of the Global Vitamin B12 (Cobalamin, Cyanocobalamin) Market Market Size Estimates: vitamin b12 (cobalamin, cyanocobalamin) market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions. Segmentation Analysis: vitamin b12 (cobalamin, cyanocobalamin) market size by type, application, and region in terms of value ($B). Regional Analysis: vitamin b12 (cobalamin, cyanocobalamin) market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the vitamin b12 (cobalamin, cyanocobalamin) market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the vitamin b12 (cobalamin, cyanocobalamin) market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model. If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more. This report answers following 11 key questions: Q.1. What are some of the most promising, high-growth opportunities for the vitamin b12 (cobalamin, cyanocobalamin) market by type (cyanocobalamin injection, cyanocobalamin oral, and cyanocobalamin spray), application (hospitals, clinics, drugstore, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)? Q.2. Which segments will grow at a faster pace and why? Q.3. Which region will grow at a faster pace and why? Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market? Q.5. What are the business risks and competitive threats in this market? Q.6. What are the emerging trends in this market and the reasons behind them? Q.7. What are some of the changing demands of customers in the market? Q.8. What are the new developments in the market? Which companies are leading these developments? Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth? Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution? Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?